Teri G. Fontenot
Teri G. Fontenot's purchase track record
Teri G. Fontenot has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/4/2024 | AMN | $100K | -4.3% | -8.9% | +7.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AMN Healthcare Maintains Outperform Rating, Target Raised to $43. Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.
Transaction History
| AMSF | ▲ Buy | Grant | 2,340 | $0 | 6/10/2026 | View on chart |
| AMSF | ▲ Buy | Grant | 1,636 | $0 | 6/6/2025 | View on chart |
| AMSF | ▲ Buy | Grant | 1,730 | $0 | 6/7/2024 | View on chart |
| AMN | ▲ Buy | Open Market | 1,732 | $100K | 3/4/2024 | View on chart |
| AMSF | ▲ Buy | Grant | 1,408 | $0 | 6/9/2023 | View on chart |
| AMSF | ▲ Buy | Grant | 1,486 | $0 | 6/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AMERISAFE trades near 52-week low with low RSI
AMERISAFE stock is currently trading near its 52-week low, with an RSI of 22.5 suggesting the stock is in oversold territory. The company offers a dividend yield of 2.63% and a trailing P/E of 9.7, while the average analyst target price stands at $35.67. Recent news coverage did not contain specific updates regarding AMERISAFE, so this entry focuses on the current technical and fundamental positioning.
AMERISAFE trades near 52-week low with low RSI. AMERISAFE stock is currently trading near its 52-week low, with an RSI of 22.5 suggesting the stock is in oversold territory. The company offers a dividend yield of 2.63% and a trailing P/E of 9.7, while the average analyst target price stands at $35.67. Recent news coverage did not contain specific updates regarding AMERISAFE, so this entry focuses on the current technical and fundamental positioning.